BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7488240)

  • 1. Cytotoxicity of BMS-181174. Effects of hypoxia, dicoumarol, and repair deficits.
    Rockwell S; Kemple B; Kelley M
    Biochem Pharmacol; 1995 Oct; 50(8):1239-43. PubMed ID: 7488240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3310-3. PubMed ID: 2470504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
    Kim SY; Rockwell S
    Oncol Res; 1995; 7(5):39-47. PubMed ID: 8534933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns.
    Bizanek R; Chowdary D; Arai H; Kasai M; Hughes CS; Sartorelli AC; Rockwell S; Tomasz M
    Cancer Res; 1993 Nov; 53(21):5127-34. PubMed ID: 7693331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
    Rockwell S; Kim SY
    Oncol Res; 1995; 7(1):39-47. PubMed ID: 7549043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of deficiencies in DNA repair on the toxicity of mitomycin C and porfiromycin to CHO cells under aerobic and hypoxic conditions.
    Hughes CS; Irvin CG; Rockwell S
    Cancer Commun; 1991 Feb; 3(2):29-35. PubMed ID: 1899798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of BMS-181174 and radiation: studies with EMT6 cells in vitro and in solid tumors.
    Rockwell S; Kelley M
    Radiother Oncol; 1996 Apr; 39(1):65-71. PubMed ID: 8735495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the cytotoxicity of mitomycin C to EMT6 mouse mammary tumor cells by dicoumarol in vitro.
    Rockwell S; Keyes SR; Sartorelli AC
    Cancer Res; 1988 Oct; 48(19):5471-4. PubMed ID: 2458178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivation of mitomycin antibiotics by aerobic and hypoxic Chinese hamster ovary cells overexpressing DT-diaphorase.
    Belcourt MF; Hodnick WF; Rockwell S; Sartorelli AC
    Biochem Pharmacol; 1996 Jun; 51(12):1669-78. PubMed ID: 8687482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
    Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
    Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative toxicities of DNA cross-links and monoadducts: new insights from studies of decarbamoyl mitomycin C and mitomycin C.
    Palom Y; Suresh Kumar G; Tang LQ; Paz MM; Musser SM; Rockwell S; Tomasz M
    Chem Res Toxicol; 2002 Nov; 15(11):1398-406. PubMed ID: 12437330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1985 Jan; 45(1):213-6. PubMed ID: 2578093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C.
    Keyes SR; Heimbrook DC; Fracasso PM; Rockwell S; Sligar SG; Sartorelli AC
    Adv Enzyme Regul; 1985; 23():291-307. PubMed ID: 3934922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase.
    Dulhanty AM; Whitmore GF
    Cancer Res; 1991 Apr; 51(7):1860-5. PubMed ID: 1900739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the superoxide dismutase inhibitor, diethyldithiocarbamate, on the cytotoxicity of mitomycin antibiotics.
    Pritsos CA; Keyes SR; Sartorelli AC
    Cancer Biochem Biophys; 1989 Oct; 10(4):289-98. PubMed ID: 2559790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a BMS-181174-resistant human bladder cancer cell line.
    Xia H; Bleicher RJ; Hu X; Srivastava SK; Gupta V; Zaren HA; Singh SV
    Br J Cancer; 1997; 76(4):461-6. PubMed ID: 9275022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents.
    Hoy CA; Thompson LH; Mooney CL; Salazar EP
    Cancer Res; 1985 Apr; 45(4):1737-43. PubMed ID: 3919945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of the cytotoxic action of the mitomycin antibiotics in hypoxic and oxygenated EMT6 cells.
    Sartorelli AC; Tomasz M; Rockwell S
    Adv Enzyme Regul; 1993; 33():3-17. PubMed ID: 8356915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual.
    Marshall RS; Paterson MC; Rauth AM
    Biochem Pharmacol; 1991 May; 41(9):1351-60. PubMed ID: 1902110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.